Back to Search
SAMUEL CHANG, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1891882460Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
48800(CA)
Research & Publications (20)
Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma.
PMID 19357966·J Neurooncol·2009
8-other
Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons.
PMID 18597936·Neurosci Lett·2008
7-preclinical
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
PMID 18559968·Neuro Oncol·2008
6-review
GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trials.
PMID 17146595·J Neurooncol·2007
6-review
Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.
PMID 16709035·Neurosurg Focus·2006
6-review
Does temsirolimus have a role in recurrent glioblastoma multiforme?
PMID 16462841·Nat Clin Pract Oncol·2006
8-other
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity.
PMID 16344479·Proc Natl Acad Sci U S A·2005
7-preclinical
GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.
PMID 16212807·Neuro Oncol·2005
6-review
Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study.
PMID 16130137·Cancer·2005
8-other
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.
PMID 16012795·Invest New Drugs·2005
3-trial
Patterns of care for adults with newly diagnosed malignant glioma.
PMID 15687310·JAMA·2005
4-observational
Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.
PMID 15380566·Int J Radiat Oncol Biol Phys·2004
3-trial
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs.
PMID 15292713·Invest New Drugs·2004
3-trial
Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors.
PMID 15234047·Int J Radiat Oncol Biol Phys·2004
3-trial
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
PMID 15073861·Cancer·2004
3-trial
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium report.
PMID 14586210·Invest New Drugs·2003
4-observational
Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project.
PMID 12816260·J Neurosurg·2003
8-other
Clinical trial participation among patients enrolled in the Glioma Outcomes Project.
PMID 12173337·Cancer·2002
4-observational
Multidisciplinary management of adult anaplastic astrocytomas.
PMID 11285554·Semin Radiat Oncol·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3327 JUDAH ST
SAN FRANCISCO, CA 94122 - Phone
- (415) 682-8088
Quick Facts
- NPI
- 1891882460
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile